Zentek Stock (NASDAQ:ZTEK)


OwnershipChart

Previous Close

$0.56

52W Range

$0.37 - $1.10

50D Avg

$0.55

200D Avg

$0.61

Market Cap

$62.30M

Avg Vol (3M)

$213.18K

Beta

0.29

Div Yield

-

ZTEK Company Profile


Zentek Ltd. is a Canadian company focused on the exploration and advancement of graphene and related nanomaterials. It fully owns the Albany Graphite project, situated in Northern Ontario, Canada. The firm develops its ZenGUARD brand, a graphene-based antimicrobial coating, incorporating it into products like surgical masks, HVAC filters, and personal protective equipment. Additionally, Zentek's innovation extends to rapid detection point-of-care diagnostics and pharmaceutical products, all leveraging graphene-based compounds. The company also specializes in synthesizing graphene, graphene oxide, and graphene quantum dots for diverse applications. Founded in 2008 and headquartered in Thunder Bay, Canada, Zentek Ltd. was formerly known as ZEN Graphene Solutions Ltd. until its name change in October 2021.

Show More

Industry

Other Precious Metals

Sector

Basic Materials

Exchange

NASDAQ

ADR

-

Country

CA

Employees

10

IPO Date

Apr 02, 2012

Website

ZTEK Performance


Peer Comparison


TickerCompany
ALXOALX Oncology Holdings Inc.
MBOTMicrobot Medical Inc.
HYFTMindWalk Holdings Corp.
AMWLAmerican Well Corporation
BYSIBeyondSpring Inc.
CRDLCardiol Therapeutics Inc.
QNCXQuince Therapeutics, Inc.
HYPRHyperfine, Inc.
MGXMetagenomi, Inc. Common Stock
GUTSFractyl Health, Inc.